Benzinga · Feb 26, 2026
IN
NYSE · INSP
Inspire Medical Systems, Inc.
Healthcare · Medical - Devices
$74.60
Up+$0.28 (+0.38%)
Updated Sep 16, 2026, 12:16 PM
SID Score
4.5/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 4.05B
- P/E ratio
- 76.09
- Dividend yield
- 0.00%
- 52-week range
- $38.91 – $147.03
- Volume
- 838.11K
- Avg. volume
- 1.3M
Price performance
INSP price history
1M range · 0 trading sessions · Daily adjusted prices
INSP does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest INSP news
The latest Smart Investors Daily articles mentioning INSP.
Stock researchCompany · Overview
INSP research
Overview
Company profile and research snapshot.
Company profile
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $139.92
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 11, 2026 | Stifel | Buy | — |
| Aug 4, 2026 | Evercore ISI Group | In-Line | — |
| Aug 4, 2026 | Piper Sandler | Neutral | — |
| Aug 4, 2026 | Baird | Neutral | — |
| Aug 4, 2026 | Oppenheimer | Outperform | — |
News briefing
No generated briefing is available yet.
Benzinga · Feb 26, 2026
Inspire Medical Systems shares are trading higher after a KeyBanc note indicated that CMS appears ready to add INSP V Specific C-Codes in April 2026 IOCE update
Benzinga · Feb 26, 2026
Inspire Medical Systems Trading Halted
Fintel · Feb 25, 2026
Inspire Medical Systems (INSP) Price Target Decreased by 27.11% to 95.55
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
